Many learners are more facile with the use of large language models in medicine than their supervisors are. The authors ...

The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain ...

Risdiplam, an oral pre–messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in ...

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.

In a phase 3a randomized trial, semaglutide at a dose of 2.4 mg with cagrilintide at a dose of 2.4 mg led to significant body-weight reduction in adults without diabetes and with overweight or ...

Semaglutide and cagrilintide have each been shown to induce weight loss, but how these drugs work in combination in patients with type 2 diabetes and overweight or obesity is unknown. New research ...

Quick Take Video Summary from The New England Journal of Medicine — Cagrilintide–Semaglutide in Adults with Overweight or Obesity ...

In this cluster-randomized, crossover trial, hospital-wide use of lactated Ringer’s solution as compared with normal saline did not alter the incidence of death or hospital readmission within 90 ...

Whether lactated Ringer’s solution is clinically superior to normal saline for routine intravenous administration of fluids to hospitalized patients is unclear. New research findings are ...

A 39-year-old man presented with a 1-day history of lower abdominal pain. The blood pressure was 203/132 mm Hg. Imaging revealed a retroperitoneal mass inferior to the aortic bifurcation.